INCLINE VILLAGE, Nev.,
Sept. 26, 2019 /PRNewswire/
-- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI)
announces that Dominique Monnet,
PDL's president and chief executive officer, will present at the
2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4, 2019, at 1:10 p.m. Eastern time (10:10 a.m. Pacific time). The conference is being
held at the Intercontinental New York Barclay Hotel.
To access the live and subsequently archived webcast of the
presentation, visit the Company's website at https://www.pdl.com/,
go to the Investor Relations section and select "Events &
Presentations." Please connect to the website at least 15 minutes
prior to the presentation to allow for any software download that
may be necessary. The archived webcast will be available for at
least seven days following the presentation.
About PDL BioPharma, Inc.
PDL's mission is to improve
the lives of patients and create value for our shareholders and our
people by applying our capital and expertise for the successful
development and commercialization of innovative therapeutics by our
partner companies. We deliver on our mission by entering into
strategic transactions involving innovative late clinical-stage or
early commercial-stage therapeutics with attractive revenue growth
potential. For more information please visit www.pdl.com.
NOTE: PDL, PDL BioPharma, the PDL logo and associated
logos and the PDL BioPharma logo are trademarks or registered
trademarks of, and are proprietary to, PDL BioPharma, Inc. which
reserves all rights therein.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-participate-in-the-2019-cantor-fitzgerald-global-healthcare-conference-300925868.html
SOURCE PDL BioPharma, Inc.